Secukinumab for moderate to severe hidradenitis suppurativa
Treatments studied
Part of Infections, Skin clinical trials.
This study tests a drug called secukinumab (a type of biologic that targets inflammation) for people with moderate to severe hidradenitis suppurativa (HS). It may be an option if you have tried other treatments and they didn't work well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have moderate to severe hidradenitis suppurativa (HS) with tunnels under the skin or at least two painful bumps.
- You have had HS for at least 6 months.
- Previous treatments like antibiotics, isotretinoin, or TNF inhibitors (a type of biologic) have not worked well enough for you.
- You do not have an active infection (like hepatitis or tuberculosis).
- You have not used other biologic drugs or strong immune-suppressing medications in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining the drug secukinumab with surgery can help people with moderate to severe hidradenitis suppurativa (HS). It looks at how well this combination works and if it is safe over a year.
This study tests if a drug called secukinumab (a self-injected biologic) is safe and effective for adults with moderate-to-severe hidradenitis suppurativa (HS) in China. It may help reduce the number of painful HS lesions.
This study tests two ways of giving the drug secukinumab for hidradenitis suppurativa (a skin condition that causes painful boils): as a cream applied to the skin or as a shot under the skin. It looks at which works better and whether they are safe.
This trial tests a new medicine called SCT650C for people with moderate to severe hidradenitis suppurativa (HS). The goal is to see if it can reduce painful bumps and abscesses better than current treatments.
This trial tests an investigational medicine, SPY072, for adults with moderate to severe hidradenitis suppurativa (also known as HS), a skin condition that causes painful lumps and sores. If you join, you'll help see if this treatment is safe and effective.
This trial looks at a type of immune cell (MAIT cells) in people with hidradenitis suppurativa (a skin condition causing painful bumps). It aims to understand how these cells work and how they relate to treatments like adalimumab, secukinumab, or bimekizumab. You may be able to join if you have moderate-to-severe HS and are about to start one of these treatments.
Hear when a new Hidradenitis Suppurativa (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.